Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Chugai Pharmaceutica ADR (CHGCY)

Chugai Pharmaceutica ADR (CHGCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 51,290,760
  • Shares Outstanding, K 3,289,978
  • Annual Sales, $ 7,891 M
  • Annual Income, $ 2,311 M
  • 60-Month Beta 0.78
  • Price/Sales 6.65
  • Price/Cash Flow 18.98
  • Price/Book 4.79
Trade CHGCY with:
  • Price/Earnings ttm 22.90
  • Earnings Per Share ttm 0.70
  • Most Recent Earnings $0.19 on 02/01/24
  • Latest Earnings Date 04/25/24 [--]
  • Annual Dividend & Yield 0.19 (1.20%)
  • Most Recent Dividend 0.098 on 06/28/23
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.17
  • Growth Rate Est. (year over year) +587,547.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.9000 +3.22%
on 04/26/24
20.1400 -23.63%
on 03/27/24
-4.2200 (-21.53%)
since 03/26/24
3-Month
14.9000 +3.22%
on 04/26/24
22.6100 -31.98%
on 03/11/24
-2.9900 (-16.28%)
since 01/26/24
52-Week
12.2800 +25.24%
on 04/27/23
22.6100 -31.98%
on 03/11/24
+2.7100 (+21.39%)
since 04/26/23

Most Recent Stories

More News
Adherex Technologies Inc. (FENC) Reports Q1 Loss, Misses Revenue Estimates

Adherex Technologies Inc. (FENC) delivered earnings and revenue surprises of -9.52% and 10.61%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

FENC : 9.21 (+0.55%)
CHGCY : 15.3800 (-1.35%)
Select Medical (SEM) Q1 Earnings and Revenues Surpass Estimates

Select Medical (SEM) delivered earnings and revenue surprises of 51.35% and 3.01%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

SEM : 27.41 (+0.07%)
CHGCY : 15.3800 (-1.35%)
3 Stocks to Consider with Earnings Approaching

As we progress through earnings season several top-rated Zacks stocks are expected to report their first quarter results on Monday, April 24.

KO : 61.74 (unch)
CHGCY : 15.3800 (-1.35%)
CDNS : 282.41 (+1.92%)
5 Diverse Medical Stocks to Buy for 2023 and Beyond

The top and bottom-line growth make these Zacks Medical stocks very attractive.

NVO : 126.85 (+0.84%)
HUM : 305.90 (-1.77%)
CHGCY : 15.3800 (-1.35%)
HZNP : 116.30 (+0.04%)
CSLLY : 89.6000 (-0.62%)
TherapeuticsMD (TXMD) Reports Q1 Loss, Misses Revenue Estimates

TherapeuticsMD (TXMD) delivered earnings and revenue surprises of -34.86% and 1.41%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

TXMD : 1.8600 (-0.53%)
CHGCY : 15.3800 (-1.35%)
Catalent (CTLT) Tops Q3 Earnings and Revenue Estimates

Catalent (CTLT) delivered earnings and revenue surprises of 10.64% and 4.38%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

CTLT : 55.92 (+0.22%)
CHGCY : 15.3800 (-1.35%)
Has Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) Outpaced Other Medical Stocks This Year?

Here is how Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) and Collegium Pharmaceutical (COLL) have performed compared to their sector so far this year.

CHGCY : 15.3800 (-1.35%)
COLL : 36.42 (+1.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

CHUGAI PHARMACEUTICAL CO. LTD. is mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products for treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases. The Company is also engaged in the provision of management services,...

See More

Key Turning Points

3rd Resistance Point 16.4033
2nd Resistance Point 16.0067
1st Resistance Point 15.6933
Last Price 15.3800
1st Support Level 14.9833
2nd Support Level 14.5867
3rd Support Level 14.2733

See More

52-Week High 22.6100
Fibonacci 61.8% 18.6639
Fibonacci 50% 17.4450
Fibonacci 38.2% 16.2261
Last Price 15.3800
52-Week Low 12.2800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar